jw001
jw001JW-001(PVC) JW001JW Pharmaceutical has presented positive preclinical data on JW0061, a novel Wnt-targeted hair loss treatment, at the U.S. Society of Investative Dermatology meeting. What are Wnt-Targeted Hair Loss
IDR 10.000
IDR 100.000
Disc -90%